Company / Operating Margin
Barinthus Biotherapeutics plc. Operating Margin History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-10463.1%
FY2024
5-year range
-16873.5% / -9.0%
FY2021-FY2024
Trend
-115642.1%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin changed -115642% YoY in FY2024, a notable deviation from the 3-year average annual change of -39833%.
Based on SEC 10-K filings.
-10463.1% in FY2024 with a 3-year CAGR of -10047.3%.
Improved from -16873.5% to -10463.1% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- -10047.3pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2024, operating margin decreased 115642.1% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.06 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | -10463.1% | -115642.1% |
| FY2023 | -9.0% | +99.9% |
| FY2022 | -16873.5% | -3958.0% |
| FY2021 | -415.8% | - |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026